Dr. Andrea Schietinger is a basic scientist and tumor immunologist. She received her graduate training at the University of Chicago in the laboratory of Dr. Hans Schreiber where she investigated the genetic creation and biochemical structures of tumor-specific glycopeptidic neoantigens. As a postdoctoral fellow at the University of Washington and the Fred Hutchinson Cancer Research Center (Seattle) in Dr. Phil Greenberg’s lab, she studied mechanisms underlying peripheral self-tolerance. Since 2015, Dr. Schietinger is an Assistant Member in the Immunology Program at Memorial Sloan Kettering Cancer Center, and Assistant Professor at Weill Cornell Medical College, New York. Her laboratory studies the molecular and epigenetic programs underlying T cell differentiation and dysfunction in the context of tumors and self-tolerance.